Canada’s National Advisory Committee on Immunization (NACI) is recommending against using the newly approved AstraZeneca COVID-19 vaccine in people 65 and older. The recommendation stems from an absence of evidence around the effectiveness of the vaccine in that population, and is unrelated to any safety concerns.